ArticleEnvironmental health : a global access science source2026
Associations of urinary bisphenol A and its emerging substitutes with subfecundity in preconception couples: a prospective nested case-control study.
Article in Environmental health : a global access science source, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Environmental estrogens and animal reproductive health: mechanisms, biomarkers, and intervention approaches.Journal of animal science and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundGlobal infertility rates have noticeably increased in recent decades. The effects of environmental exposures on human fertility have been well-noted. However, Evidence on couple-based preconception exposure to bisphenols (BPs), particularly emerging substitutes, and fecundity remains limited. This study aimed to investigate the exposure profiles of 14 classic and emerging BPs in the preconception period as well as their impacts on couple fecundity, to assess both the individual effects of specific compounds and the combined effects of mixtures in males and females, and to evaluate the health risks induced by BPs exposure after tolerable daily intake (TDI) value was tightened in 2023.
methodsThis nested case-control study involved 1934 preconception individuals in two research sites of China, from October 2016 to May 2025. The case and control groups were comprised of 318 and 649 couples with time to pregnancy (TTP) > 12 and ≤ 12 menstrual cycles, respectively. BPs were quantified in preconception urine samples using ultra-performance liquid chromatography-tandem mass spectrometry, including novel substitutes that had not been measured and reported in human beings, such as 2,2’-diallyl bisphenol A (DBA) and 4-hydroxy-4’-isopropoxydiphenylsulfone (D8). Generalized linear, weighted quantile sum and Bayesian kernel machine regression models were employed to assess individual and mixture effects of BPs on subfecundity.
resultsThe positive associations of BPs and subfecundity risks were observed in both females and males. Mixed BPs were positively correlated with subfecundity in females (OR = 2.84, 95% CI: 2.23–3.61), males (OR = 4.21, 95% CI: 3.24–5.47), and couples (OR = 6.73, 95% CI: 4.81–9.41), with DBA and bisphenol AF (BPAF) identified as major contributors. Health risk assessment indicated that although few participants had an estimated daily intake (EDI) exceeding the 2015 TDI (4000 ng/kg bw/day), most (81.8%-100%) surpassed the 2023 TDI (0.2 ng/kg bw/day).
conclusionsThis study provides the first evidence linking novel bisphenols, BPAF and DBA, to increased subfecundity risk and highlights significant health risks in a population with an intention to conceive, underscoring the urgency to regulate a broader range of bisphenols to protect reproductive health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.